Presentation description

Traumatic brain injury (TBI) is the leading cause of death and disability due to trauma and the leading cause of acquired neurological disability in children. Specific therapies to optimize recovery after TBI are lacking. Docosahexaenoic acid (DHA), a component of fish oil and a natural constituent of brain cell membranes, is a potential candidate therapy to improve neurologic recovery after severe TBI. The objective of our project is to test the hypothesis that DHA improves cognitive outcome.